Business
Galderma Welcomes Increased Equity Investment From L’Oréal
ZUG, Switzerland, December 08, 2025--Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced that L’Oréal Groupe intends to increase its equity investment in the company, acquiring an additional 10% stake from Sunshine SwissCo GmbH (a consortium led by EQT, Abu Dhabi Investment Authority (ADIA), and Auba Investment Pte. Ltd., acting as sellers).
About this update from Galderma Group Ag
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":823,"height":209,"url":"https://media.zenfs.com/en/business-wire.com/b6a44e8bc55a07bc20cad1987deeda0f"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/sTYR42jMT98MjpmuOfrf6w--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTI0NDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/b6a44e8bc55a07bc20cad1987deeda0f","width":823,"height":209},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/Elfivfrin5FbT_gGiQBiAw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTE2NDY7aD00MTg7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/b6a44e8bc55a07bc20cad1987deeda0f","width":823,"height":209}},"lazy":false},{"type":"text","content":"L’Oréal to acquire an additional 10% stake in Galderma recognizing its scientific leadership in dermatology and long-term growth potential","length":138,"tagName":"p"},{"type":"text","content":"Ad hoc announcement pursuant to Art. 53 LR","length":42,"tagName":"p"},{"type":"text","content":"ZUG, Switzerland, December 08, 2025--(BUSINESS WIRE)--Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced that L’Oréal Groupe intends to increase its equity investment in the company, acquiring an additional 10% stake from Sunshine SwissCo GmbH (a consortium led by EQT, Abu Dhabi Investment Authority (ADIA), and Auba Investment Pte. Ltd., acting as sellers).","length":397,"tagName":"p"},{"type":"text","content":"Following the transaction, which is subject to customary approvals, L’Oréal’s total shareholding in Galderma will rise to 20%, building on its initial investment made in August 2024. The transaction is expected to close in Q1 2026.","length":231,"tagName":"p"},{"type":"text","content":"In connection with this increased investment, Galderma will consider nominating two non-independent board candidates from L’Oréal, replacing the board members representing the consortium led by EQT, at the 2026 Annual General Meeting.","length":234,"tagName":"p"},{"type":"text","content":"Additionally, Galderma and L’Oréal aim at exploring additional scientific research projects of mutual interest. This ongoing collaboration brings together Galderma’s scientific leadership in dermatology and L’Oréal’s expertise as the world’s leading beauty player. With a shared focus on skincare and skin h...